Atrás
Rango del Día
$90.61
$90.61
Rango de 52 Semanas
$90.61
$90.61
Volumen
100
Promedio 50D / 200D
$90.61
/
$90.61
Cierre Anterior
$90.61
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 33.0 | 0.4 |
| P/B | 7.0 | 2.9 |
| ROE % | 22.7 | 3.8 |
| Net Margin % | 18.9 | 3.9 |
| Rev Growth 5Y % | 3.5 | 10.0 |
| D/E | 0.2 | 0.2 |
Puntos Clave
Revenue grew 3.46% annually over 5 years — modest growth
ROE of 22.71% indicates high profitability
Net margin of 18.89% shows strong profitability
Debt/Equity of 0.22 — conservative balance sheet
Generating 120.12M in free cash flow
P/E of 33.01 — premium valuation
Crecimiento
Revenue Growth (5Y)
3.46%
Revenue (1Y)-2.69%
Earnings (1Y)2.56%
FCF Growth (3Y)43.83%
Calidad
Return on Equity
22.71%
ROIC16.02%
Net Margin18.89%
Op. Margin23.29%
Seguridad
Debt / Equity
0.22
Current Ratio3.14
Interest Coverage60.84
Valoración
P/E Ratio
33.01
P/B Ratio6.98
EV/EBITDA27.06
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.69% | Revenue Growth (3Y) | -5.34% |
| Earnings Growth (1Y) | 2.56% | Earnings Growth (3Y) | -9.21% |
| Revenue Growth (5Y) | 3.46% | Earnings Growth (5Y) | -2.14% |
| Profitability | |||
| Revenue (TTM) | 743.20M | Net Income (TTM) | 140.39M |
| ROE | 22.71% | ROA | 14.70% |
| Gross Margin | 60.75% | Operating Margin | 23.29% |
| Net Margin | 18.89% | Free Cash Flow (TTM) | 120.12M |
| ROIC | 16.02% | FCF Growth (3Y) | 43.83% |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 3.14 |
| Interest Coverage | 60.84 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 33.01 | P/B Ratio | 6.98 |
| P/S Ratio | 6.24 | PEG Ratio | 9.38 |
| EV/EBITDA | 27.06 | Dividend Yield | 0.01% |
| Market Cap | 4.63B | Enterprise Value | 4.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 743.20M | 763.75M | 829.51M | 817.70M | 648.68M |
| Net Income | 140.39M | 136.88M | 170.34M | 199.67M | 153.08M |
| EPS (Diluted) | 2.75 | 2.67 | 3.20 | 3.73 | 2.76 |
| Gross Profit | 451.48M | 467.71M | 483.34M | 512.43M | 379.84M |
| Operating Income | 173.08M | 179.55M | 220.25M | 255.85M | 181.39M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 955.33M | 832.02M | 799.88M | 878.70M | 732.68M |
| Total Liabilities | 276.69M | 250.48M | 256.39M | 357.32M | 261.70M |
| Shareholders' Equity | 664.17M | 572.03M | 539.39M | 520.01M | 470.98M |
| Total Debt | 146.03M | 114.41M | 65.43M | 72.14M | 73.15M |
| Cash & Equivalents | 97.94M | 27.19M | 25.32M | 124.95M | 99.04M |
| Current Assets | 569.44M | 489.61M | 509.33M | 623.07M | 506.36M |
| Current Liabilities | 181.19M | 156.65M | 199.84M | 293.89M | 190.39M |